Gliptins vs. Milk-derived Dipeptidyl-Peptidase IV Inhibiting Biopeptides: Physicochemical Characterization and Pharmacokinetic Profiling
Background: Milk-derived biopeptides have reported in vitro dipeptidyl-peptidase IV (DPP-IV) inhibition, suggesting a glycemic-regulatory effect in Type 2 Diabetes Mellitus (T2DM). Nonetheless, the therapeutic application of these nutraceuticals is limited by the scarcity of knowledge regarding the...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Universidad de Antioquia
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b54a861ec7f74571ad98ecd6286ca34c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|